Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: prospective single‐center study

I Sakellari, E Gavriilaki, I Batsis… - Journal of Clinical …, 2018 - Wiley Online Library
Background Graft vs host disease (GVHD) is the most severe complication of allogeneic
hematopoietic cell transplantation. Conventional immunosuppressive therapy increases …

Extracorporeal photopheresis in acute and chronic graft-versus-host disease

HT Greinix, N Worel, U Just, R Knobler - Transfusion and Apheresis …, 2014 - Elsevier
Graft-versus-host disease (GvHD) is a serious complication of allogeneic hematopoietic cell
transplantation causing significant morbidity and mortality. Corticosteroids are the …

Extracorporeal photopheresis in the treatment of acute graft‐versus‐host disease: a single‐center experience

R Niittyvuopio, E Juvonen, J Heiskanen… - …, 2018 - Wiley Online Library
BACKGROUND Steroid‐refractory acute graft‐versus‐host disease (aGVHD) is a serious
complication after hematopoietic stem cell transplantation. The long‐term outcome of the …

Extracorporeal photopheresis in the treatment of acute and chronic graft-versus-host disease: A position statement from the Turkish Society of Apheresis (TSA)

L Kaynar, E Tekgunduz, I Kozanoglu, HA Ozkan… - … and Apheresis Science, 2022 - Elsevier
Graft versus host disease (GVHD) is still the most important cause of mortality and morbidity
after allogeneic stem cell transplantation. Though perfect response rates are not achieved …

[HTML][HTML] Retrospective multicenter study of extracorporeal photopheresis in steroid-refractory acute and chronic graft-versus-host disease

G Oarbeascoa, ML Lozano, LM Guerra… - Biology of Blood and …, 2020 - Elsevier
Extracorporeal photopheresis (ECP) is an established treatment strategy in steroid-refractory
graft-versus-host disease (GVHD). This study's main objective was to analyze the clinical …

Extracorporeal photopheresis in graft-versus-host disease

B Drexler, A Buser, L Infanti, G Stehle, J Halter… - Transfusion Medicine …, 2020 - karger.com
Abstract Background and Summary: Extracorporeal photopheresis (ECP) is a leukapheresis-
based procedure used in the therapy of acute and chronic graft-versus-host disease …

Longitudinal follow-up of response status and concomitant immunosuppression in patients treated with extracorporeal photopheresis for chronic graft versus host …

M Nygaard, T Karlsmark, NS Andersen… - Bone Marrow …, 2019 - nature.com
Improvement in chronic graft vs. host disease (cGvHD) following treatment with
extracorporeal photopheresis (ECP) has been shown previously. However, the effect is often …

Extracorporeal photopheresis for graft‐versus‐host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome—results from …

M Berger, R Albiani, B Sini, F Fagioli - Transfusion, 2015 - Wiley Online Library
Background Extracorporeal photopheresis (ECP) has been shown as active therapy for graft‐
versus‐host disease (GVHD). Study Design and Methods The aim was to ascertain the role …

[HTML][HTML] Extracorporeal photopheresis in steroid-refractory acute or chronic graft-versus-host disease: results of a systematic review of prospective studies

I Abu-Dalle, T Reljic, T Nishihori, A Antar… - Biology of Blood and …, 2014 - Elsevier
Acute and chronic graft-versus-host disease (GVHD) remain major obstacles for successful
allogeneic hematopoietic cell transplantation. Extracorporeal photopheresis (ECP) …

Steroid-sparing effect of extracorporeal photopheresis in the therapy of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

M Ussowicz, J Musiał, M Mielcarek… - Transplantation …, 2013 - Elsevier
Introduction Steroid-refractory graft-versus-host disease (GVHD) remains a challenging
therapeutic problem after allogeneic hematopoietic stem cell transplantation (HSCT). The …